Patent · US Active

Recombinant gene which enhances the ability of fish to tolerate low dissolved oxygen stress and the use thereof

US8546644B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 10, 2010
Grant dateOct 1, 2013
Priority date
Expiry dateSep 30, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/85
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention discloses a recombinant gene which enhances the ability of fish to tolerate low dissolved oxygen (DO) stress and the use thereof. Carp β-actin gene promoter is used as a promoter and Vitreoscilla hemoglobin gene is used as a target gene, so as to construct the recombinant Vitreoscilla hemoglobin gene driven by carp β-actin promoter. The modeling organism zebrafish is used as the research object, and the recombinant gene is microinjected into zygotes of zebrafish. After PCR screening and 156 h low DO stress test, transgenic fish are obtained with a survival rate of 92%, which is significantly different from the survival rate of 65% of the control fish group. The vhb transgenic zebrafish obtain hypoxia tolerance. When the recombinant gene is applied to the economically farmed species, i.e., blunt snout bream (Megalobrama amblycephala) and common carp (Cyprinus carpio L.), it enhances their hypoxia tolerance as well. Such genetically improved breeding technique may be widely used for breeding new excellent farmed species with the hypoxia tolerance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.